Detalhe da pesquisa
1.
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters.
J Med Virol
; 95(1): e28258, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305052
2.
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial.
Clin Infect Dis
; 75(12): 2088-2096, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543372
3.
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
Trials
; 23(1): 498, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710572